Final results from a phase 3 trial with the investigational DCVax-L vaccine show that overall survival was increased both in patients with newly diagnosed glioblastoma as well as recurrent disease.
Medscape spoke to an expert about how glioblastomas are treated, the role that vaccinations play, and what therapeutic approaches might be derived from the discovery of how glioblastomas spread in the brain.
Following tumor removal, an absorbable collagen tile delivers a controlled and therapeutic dose of radiation targeting remaining tumor cells and sparing healthy tissue, new research suggests.
Most notably, the team found that frailty had no effect on surgical outcomes. The study was published as a preprint and has not yet been peer reviewed.